copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
MED-LIFE DISCOVERIES *MLD’s plasmalogen therapeutics are currently undergoing required formal regulatory safety and efficacy studies and are not currently available to the public
SASKATOON-BASED BIOPHARMA COMPANY MED-LIFE . . . - MED-LIFE DISCOVERIES MLD has received a No Objection Letter (“NOL”) from Health Canada to begin a Phase 1 healthy adult trial for lead compound PPI-1011 This is a milestone on the path towards a potential therapy for children with RCDP
Corporate — MED-LIFE DISCOVERIES Dr Ritchie is the CEO and CSO of MLD, and is responsible for the scientific and strategic direction of the company Dr Ritchie obtained his BSc (honours) in Biochemistry (University of Saskatchewan), a degree in Technical Writing and Communications (Simon Fraser University), and a PhD in Biochemistry (University of Saskatchewan) Dr
News — MED-LIFE DISCOVERIES MLD Announces Completion of Dosing with Plasmalogen-precursor PPI-1011 in its Phase I Clinical Trial
Multiple ascending dose study of PPI-1011 begins dosing MLD is a biopharma company located in Saskatoon, Saskatchewan, Canada which is developing a pipeline of plasmalogen-based drugs, including PPI-1011, for RCDP and other neurological indications
MLD to build new GLP laboratory facilities in Saskatoon MLD is pleased to announce the construction of a new GLP analytical lab facility in Saskatoon SK The lab will be located in the Atrium Building within the Innovation Place research park and will house several mass spectrometry and other analytical platforms
MLD creates spin-out company GraySpace Therapeutics The fact that there is already substantial data collected on this lead compound in combination with full access to know-how and expertise developed at MLD puts GraySpace in an excellent position to successfully advance PPI-1011 into the clinic ”
MLD Obtains Analytical Cannabis License from Health Canada MLD’s lab, located at Innovation Place in Saskatoon, is nearing completion of Good Laboratory Practise (GLP) accreditation, an exceptionally high laboratory quality standard
MLD and U of C Secure Metabolomic CRC Screening Grant MLD is a biopharmaceutical and diagnostics company dedicated to the early detection and prevention of chronic disease The company is based out of Saskatoon, SK, Canada and works with collaborators and partners world-wide